Ireland’s health innovation ecosystem continues to gather pace, and the latest irish tech news highlights a major step forward from Cork. NeuroBell has raised $5.5m to accelerate the international rollout of Luna, its AI-powered neonatal brain monitor designed to detect seizures in newborns faster and more reliably in intensive care settings.
The funding round was led by Elkstone, with backing from Parkview Health, Furthr, Atlantic Bridge, Medtech Syndicate and Enterprise Ireland. For anyone tracking technology news ireland, this deal is another sign that high-impact founders in the country are attracting strong investor confidence, especially in specialist healthcare and diagnostics.
Why this irish tech news matters
NeuroBell sits at the intersection of medtech innovation ireland, AI diagnostics and hospital monitoring. Its compact wireless EEG device, Luna, is designed for bedside use in neonatal intensive care units, helping clinicians identify seizures that may not show visible symptoms. That matters because delayed detection can increase the risk of long-term brain injury in infants.
This funding also adds to wider irish biotech news and startup momentum. NeuroBell is a University College Cork spin-out founded in 2023 by Dr Mark O’Sullivan, Dr Alison O’Shea and Colm Murphy, following years of academic research into newborn brain health. The company’s progress reflects how high potential startups ireland are moving from research labs into commercially scalable healthcare products.
- $5.5m raised to support growth and regulatory progress
- Luna offers AI-assisted seizure detection and remote review capabilities
- The company is targeting US clearance this year
- NeuroBell has already opened a US office in Fort Wayne, Indiana
Funding, expansion and irish tech industry updates
From an investment perspective, this story fits broader irish tech industry updates around ambitious deep-tech and clinical startups winning support from both domestic and international backers. Enterprise Ireland’s involvement reinforces the role of enterprise ireland tech funding in helping Irish companies move into global markets, while Atlantic Bridge’s participation aligns with continued venture capital funding ireland activity in advanced technology sectors.
The Parkview Health investment is especially notable. Beyond capital, it brings strategic validation from a major US healthcare provider. That kind of partnership can be crucial for founders navigating hospital adoption, real-world testing and international market entry.
A strong signal for Cork and Irish medtech
Although much of dublin tech news often focuses on fintech, software and multinational activity, this development underlines the growing importance of regional innovation hubs. Cork is strengthening its role in the national startup landscape, while the west continues to contribute through the galway medtech sector. Together, these clusters support the case for why tech companies choose ireland: research links, skilled talent and active investor networks.
NeuroBell’s rise also connects with trends in ai adoption irish businesses, particularly where AI is used for practical, high-stakes decision support rather than hype-driven experimentation. In neonatal care, faster data interpretation can directly improve patient outcomes.
What this means for ireland tech startups
For founders, investors and readers following irish tech news, NeuroBell’s raise is more than a single funding announcement. It shows how Irish startups can build clinically meaningful products, win institutional backing and expand into the US without losing their research roots.
As ireland tech startups continue to scale across medtech, SaaS, fintech and AI, stories like this demonstrate the strength of the country’s commercialization pipeline. The clearest takeaway from this irish tech news update is simple: Ireland’s next wave of global tech growth is increasingly being shaped by companies solving urgent real-world problems.
